FTRE earnings analysis
What we found in FTRE's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Fortrea’s Q2 showed a meaningful earnings and margin recovery: revenue of $678.2 million was still 4.5% below last year, but gross margin improved 170 bps to 20.5% and operating margin returned to roughly 2.2%. The GAAP loss narrowed to $0.14 per share from $4.14 a year earlier, principally because the prior period carried a $309.1 million impairment, while cost actions reduced SG&A and restructuring costs. Liquidity appears adequate, with $168.6 million of cash and $447.7 million of unused revolver capacity, although organic revenue and FSP demand remain key execution risks.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue rose sequentially despite YoY decline
- Q2 revenue was $678.2 million, down 4.5% year over year from $710.3 million, but increased 6.5% sequentially from $636.5 million in Q1 2026. The year-over-year decline reflected a 4.9% organic-revenue decline, partly offset by 0.4% favorable FX.
- Gross margin expanded 170 bps YoY
- Gross margin expanded to 20.5% from 18.8% in Q2 2025 and 19.4% in Q1 2026. Direct costs declined 6.6% to $539.0 million, faster than the 4.5% revenue decline, helped by lower pass-through, stock-based compensation and personnel costs.
- Operations returned to positive profitability
- Operating income was approximately $14.8 million, or a 2.2% operating margin, versus an approximately $323.6 million operating loss in Q2 2025, which included $309.1 million of goodwill and other asset impairments. SG&A fell 18.2% to $102.1 million and restructuring charges fell 73.8% to $2.7 million.
- GAAP EPS loss narrowed materially
- GAAP diluted EPS improved to a loss of $0.14 from a $4.14 loss in Q2 2025 and a $0.25 loss in Q1 2026. The year-over-year improvement was aided by the absence of the prior-year $309.1 million impairment charge.
- Operating cash flow inflected positive
- First-half operating cash flow turned positive at $11.9 million, an improvement of $114.3 million from $102.4 million used in the prior-year period. Capital spending was $17.0 million, or 1.3% of first-half revenue of $1.315 billion.
- Cash and revolver capacity support liquidity
- Liquidity improved: cash was $168.6 million at June 30, 2026, while the revolver had no outstanding balance and $447.7 million of availability. The receivables facility was extended to February 23, 2029, with $300.0 million of receivables sold as of quarter-end.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Organic revenue and FSP demand declined
- Revenue remained under pressure, declining 4.5% year over year to $678.2 million as organic revenue fell 4.9%; management cited lower pass-through costs and lower Functional Service Provider demand.
- GAAP loss and tax drag persisted
- The company remained GAAP unprofitable, reporting a $0.14 diluted loss per share and $12.0 million of income-tax expense despite approximately $14.8 million of operating income. Management cited valuation allowance effects tied primarily to expected interest-deductibility limitations.
- Variable-rate debt creates interest sensitivity
- Debt and rate exposure remain meaningful: variable-rate debt outstanding was $572.0 million, and a hypothetical 1% increase in rates would increase interest expense by $5.7 million. Total interest expense was $19.3 million in Q2.
- Backlog conversion is not assured
- Backlog was $7.8 billion at June 30, 2026, but contracts generally permit early termination with 30-to-90-day notice periods; management cautions it does not generally have a contractual right to the full award amount in backlog.
- No new material risk-factor disclosures
- No material risk-factor changes were reported versus the December 31, 2025 Form 10-K. The filing explicitly states there were no material changes to previously disclosed risk factors.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.14
- Gross margin
- 20.5%
- Operating margin
- 2.2%
What they said about what is next.
The 10-Q contains no quantitative revenue or EPS outlook; management states that existing cash, operating cash flow and credit facilities are expected to fund current and planned operations for at least the next 12 months.
The filing reads better than the one before it.
What came before.
- 10-Q · May 5, 2026
- Fortrea Holdings (FTRE) reported Q1 2026 results with revenues of $636.5 million, marking a slight decline of 2.3% year-over-year, while earnings per share (EPS) improved to $0.16, significantly exceeding expectations.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing FTRE makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever